BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24897401)

  • 1. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study.
    Sargentini V; Ceccarelli G; D'Alessandro M; Collepardo D; Morelli A; D'Egidio A; Mariotti S; Nicoletti AM; Evangelista B; D'Ettorre G; Angeloni A; Venditti M; Bachetoni A
    Clin Chem Lab Med; 2015 Mar; 53(4):567-73. PubMed ID: 24897401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.
    Mussap M; Puxeddu E; Puddu M; Ottonello G; Coghe F; Comite P; Cibecchini F; Fanos V
    Clin Chim Acta; 2015 Dec; 451(Pt A):65-70. PubMed ID: 26232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathfast presepsin assay for early diagnosis of systemic inflammatory response syndrome in patients with nephrolithiasis.
    Hou YS; Wang H; Chen H; Wu LF; Lu LF; He Y
    Biomed Res Int; 2015; 2015():792572. PubMed ID: 25722986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
    Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P
    World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.
    Ali FT; Ali MA; Elnakeeb MM; Bendary HN
    Clin Chim Acta; 2016 Sep; 460():93-101. PubMed ID: 27353646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
    Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
    Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis.
    Cakır Madenci Ö; Yakupoğlu S; Benzonana N; Yücel N; Akbaba D; Orçun Kaptanağası A
    Burns; 2014 Jun; 40(4):664-9. PubMed ID: 24074718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis.
    Vodnik T; Kaljevic G; Tadic T; Majkic-Singh N
    Clin Chem Lab Med; 2013 Oct; 51(10):2053-62. PubMed ID: 23740685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
    Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
    J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.
    Ulla M; Pizzolato E; Lucchiari M; Loiacono M; Soardo F; Forno D; Morello F; Lupia E; Moiraghi C; Mengozzi G; Battista S
    Crit Care; 2013 Jul; 17(4):R168. PubMed ID: 23899120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of Presepsin Measurement: A New Biomarker for Sepsis].
    Okamura Y
    Rinsho Byori; 2015 Jan; 63(1):62-71. PubMed ID: 26524880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis.
    Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S
    Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study.
    Takahashi G; Shibata S; Ishikura H; Miura M; Fukui Y; Inoue Y; Endo S
    Eur J Anaesthesiol; 2015 Mar; 32(3):199-206. PubMed ID: 25387303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department.
    Romualdo LG; Torrella PE; González MV; Sánchez RJ; Holgado AH; Freire AO; Acebes SR; Otón MD
    Clin Biochem; 2014 May; 47(7-8):505-8. PubMed ID: 24560955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the value of dynamic procalcitonin and presepsin measurements for patients with severe sepsis.
    Yu H; Qi Z; Hang C; Fang Y; Shao R; Li C
    Am J Emerg Med; 2017 Jun; 35(6):835-841. PubMed ID: 28153679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
    Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
    Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department.
    de Guadiana Romualdo LG; Torrella PE; Acebes SR; Otón MDA; Sánchez RJ; Holgado AH; Santos EJ; Freire AO
    Clin Chim Acta; 2017 Jan; 464():6-11. PubMed ID: 27823951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of presepsin for the evaluation of sepsis in the emergency department.
    Pizzolato E; Ulla M; Galluzzo C; Lucchiari M; Manetta T; Lupia E; Mengozzi G; Battista S
    Clin Chem Lab Med; 2014 Oct; 52(10):1395-400. PubMed ID: 24897403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.
    Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A
    J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
    Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
    Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.